Ladenburg Thalmann Financial Services’s ProShares Ultra NASDAQ Biotechnology BIB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | $37K | Buy |
600
+500
| +500% | +$30.8K | ﹤0.01% | 3725 |
|
|
2019
Q3 | $4K | Hold |
100
| – | – | ﹤0.01% | 4749 |
|
|
2019
Q2 | $5K | Hold |
100
| – | – | ﹤0.01% | 4698 |
|
|
2019
Q1 | $6K | Hold |
100
| – | – | ﹤0.01% | 4572 |
|
|
2018
Q4 | $4K | Hold |
100
| – | – | ﹤0.01% | 4662 |
|
|
2018
Q3 | $7K | Hold |
100
| – | – | ﹤0.01% | 4431 |
|
|
2018
Q2 | $6K | Hold |
100
| – | – | ﹤0.01% | 4494 |
|
|
2018
Q1 | $6K | Hold |
100
| – | – | ﹤0.01% | 4494 |
|
|
2017
Q4 | $6K | Hold |
100
| – | – | ﹤0.01% | 4433 |
|
|
2017
Q3 | $6K | Sell |
100
-157
| -61% | -$9.42K | ﹤0.01% | 4306 |
|
|
2017
Q2 | $13K | Buy |
257
+77
| +43% | +$3.9K | ﹤0.01% | 3857 |
|
|
2017
Q1 | $9K | Sell |
180
-120
| -40% | -$6K | ﹤0.01% | 4033 |
|
|
2016
Q4 | $12K | Hold |
300
| – | – | ﹤0.01% | 3766 |
|
|
2016
Q3 | $15K | Hold |
300
| – | – | ﹤0.01% | 3558 |
|
|
2016
Q2 | $12K | Buy |
300
+200
| +200% | +$8K | ﹤0.01% | 3648 |
|
|
2016
Q1 | $4K | Sell |
100
-491
| -83% | -$19.6K | ﹤0.01% | 4141 |
|
|
2015
Q4 | $42K | Buy |
591
+383
| +184% | +$27.2K | ﹤0.01% | 2684 |
|
|
2015
Q3 | $15K | Sell |
208
-702
| -77% | -$50.6K | ﹤0.01% | 3268 |
|
|
2015
Q2 | $81K | Buy |
910
+710
| +355% | +$63.2K | ﹤0.01% | 2242 |
|
|
2015
Q1 | $15K | Buy |
+200
| New | +$15K | ﹤0.01% | 3356 |
|